Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Caspase-3 Fluorometric Assay Kit: Quantitative DEVD-Depen...

    2025-12-22

    Caspase-3 Fluorometric Assay Kit: Quantitative DEVD-Dependent Apoptosis Detection

    Executive Summary: The Caspase-3 Fluorometric Assay Kit (APExBIO, K2007) quantitatively detects DEVD-dependent caspase activity via release of fluorescent AFC from the DEVD-AFC substrate [product page]. Caspase-3 is a cysteine-dependent aspartate-directed protease that mediates apoptosis by cleaving downstream caspases and key cellular substrates [Yao et al., 2020]. The kit supports sensitive, reproducible measurements in less than two hours and is validated for quantitative comparison between apoptotic and control samples. DEVD-AFC cleavage and fluorescence detection at 505 nm enables high-throughput screening and mechanistic studies. Proper storage at -20°C ensures substrate stability and assay integrity.

    Biological Rationale

    Caspase-3 is a central executioner in the apoptosis pathway. It is activated by initiator caspases (caspase-8, -9, -10) in response to intrinsic or extrinsic death signals [Yao et al., 2020]. Once active, caspase-3 cleaves downstream effector caspases (6 and 7) and cellular proteins, leading to DNA fragmentation, membrane blebbing, and cell death. Dysregulation of caspase-3 activity is implicated in cancer, neurodegeneration (e.g., Alzheimer’s disease), and inflammatory disorders. Quantitative detection of caspase-3 is essential for apoptosis research, drug screening, and mechanistic studies in cell biology [internal article]. This article extends previous guidance by focusing on practical integration and benchmarking in diverse research applications.

    Mechanism of Action of Caspase-3 Fluorometric Assay Kit

    The Caspase-3 Fluorometric Assay Kit utilizes a synthetic fluorogenic substrate, DEVD-AFC. Caspase-3 specifically recognizes the DEVD (Asp-Glu-Val-Asp) tetrapeptide motif and hydrolyzes the peptide bond C-terminal to the second aspartic acid. Upon cleavage, the AFC (7-amino-4-trifluoromethylcoumarin) moiety is released, emitting yellow-green fluorescence (λmax = 505 nm) measurable by a standard fluorescence microplate reader or fluorometer. The assay includes Cell Lysis Buffer, 2X Reaction Buffer, 1 mM DEVD-AFC, and 1 M DTT for reducing conditions. The reaction occurs at 37°C and is complete within 1–2 hours. The fluorescence output is directly proportional to caspase-3 activity present in the sample [internal article], clarifying mechanistic detail beyond previous overviews.

    Evidence & Benchmarks

    Applications, Limits & Misconceptions

    The Caspase-3 Fluorometric Assay Kit is used for:

    • Quantifying apoptosis in cancer research, including drug response and resistance studies.
    • Measuring caspase-3 activity in neurodegenerative disease models, such as Alzheimer's disease research.
    • Screening small molecules or genetic interventions affecting the caspase signaling pathway.
    • Comparing caspase activity between treated and control cell populations with high sensitivity.

    The kit should not be used for diagnostic or clinical purposes, as stated by APExBIO. It is validated for cell and tissue lysates but not for intact tissue sections or live-cell imaging. For more on protocol extensions and troubleshooting, see this internal guide, which this article extends by focusing on benchmarking evidence and workflow integration.

    Common Pitfalls or Misconceptions

    • The kit does not distinguish between caspase-3 and closely related caspases (e.g., caspase-7) if present at high levels; confirm specificity using inhibitors.
    • Not suitable for live-cell or in vivo imaging due to cell lysis requirement.
    • Assay sensitivity can be compromised if reagents are not stored at -20°C as recommended.
    • The fluorescence signal is not directly proportional to caspase concentration at substrate saturation; always run standard curves.
    • Not appropriate for clinical diagnostics or patient testing; for research use only.

    Workflow Integration & Parameters

    The K2007 kit supports a one-step procedure: lyse cells, add reaction buffer and substrate, incubate at 37°C, and measure fluorescence at 505 nm. Optimal cell density is 1–5 x 106 cells per reaction. The kit is compatible with 96-well and 384-well plates for high-throughput workflows. Store all components at -20°C; avoid repeated freeze-thaw cycles. The reaction buffer includes DTT to maintain reducing conditions, essential for caspase activity. Data analysis involves calculating AFC released over time, compared to an AFC standard curve. For protocol troubleshooting, see this protocol-focused article; this page provides updated benchmarks and integration tips.

    Conclusion & Outlook

    The Caspase-3 Fluorometric Assay Kit (APExBIO K2007) provides rapid, sensitive, and quantitative detection of DEVD-dependent caspase activity, enabling robust apoptosis research. Its workflow simplicity and validated benchmarks support diverse applications in oncology, neurobiology, and cell signaling studies. Proper use and awareness of kit limitations ensure high-quality, reproducible data. Ongoing advances may soon extend applications to complex tissue models and multiplexed screening platforms. For full specifications, visit the Caspase-3 Fluorometric Assay Kit product page.